118 related articles for article (PubMed ID: 3346155)
1. Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
Bashan N; Peleg N; Moses SW
Isr J Med Sci; 1988 Jan; 24(1):61-4. PubMed ID: 3346155
[No Abstract] [Full Text] [Related]
2. Pharmacogenetic interactions in G6PD deficiency and development of an in vitro test to predict a drug's hemolytic potential.
Magon A; Leipzig RM; Bloom K; Brewer GJ
Prog Clin Biol Res; 1981; 55():709-24. PubMed ID: 7291202
[TBL] [Abstract][Full Text] [Related]
3. Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
Ali NA; al-Naama LM; Khalid LO
East Mediterr Health J; 1999 May; 5(3):457-64. PubMed ID: 10793824
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced hemolysis: biochemical considerations.
Shahidi NT
Birth Defects Orig Artic Ser; 1970 Jun; 6(2):9-15. PubMed ID: 5522339
[No Abstract] [Full Text] [Related]
5. Interactions of glucose-6-phosphate dehydrogenase deficiency with drug acetylation and hydroxylation reactions.
Magon AM; Leipzig RM; Zannoni VG; Brewer GJ
J Lab Clin Med; 1981 Jun; 97(6):764-70. PubMed ID: 7229511
[TBL] [Abstract][Full Text] [Related]
6. Hemolysis by diphenylsulfones: comparative effects of DDS and hydroxylamine-DDS.
Glader BE; Conrad ME
J Lab Clin Med; 1973 Feb; 81(2):267-72. PubMed ID: 4683425
[No Abstract] [Full Text] [Related]
7. The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
Wang YM; Patterson JH; Van Eys J
J Clin Invest; 1971 Jul; 50(7):1421-8. PubMed ID: 4397414
[TBL] [Abstract][Full Text] [Related]
8. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
Grossman S; Budinsky R; Jollow D
J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
[TBL] [Abstract][Full Text] [Related]
9. [Glucose-6-phosphate-dehydrogenase (IV) enzymopathy. Normal and pathological metabolism of erythrocytes. Mechanism of hyperhemolysis].
Mora Lara RJ; Núñez Carril J; Rodríguez Cuartero A; Candel Delgado JM
Rev Clin Esp; 1973 Dec; 131(5):349-54. PubMed ID: 4779092
[No Abstract] [Full Text] [Related]
10. The hemolytic effect of various sulfonamides on subjects with a deficiency of glucose-6-phosphate dehydrogenase of erythrocytes.
SZEINBERG A; PRAS M; SHEBA C; ADAM A; RAMOT B
Isr Med J; 1959; 18():176-83. PubMed ID: 13836343
[No Abstract] [Full Text] [Related]
11. Effects of drugs and drug metabolites on erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient individuals.
Fraser IM; Vesell ES
Ann N Y Acad Sci; 1968 Jul; 151(2):777-94. PubMed ID: 4391843
[No Abstract] [Full Text] [Related]
12. [Formate incubation of red blood cells from glucose-6-phosphate-dehydrogenase-deficient patients].
Grieger M; Schippel W; Siems W; Leppin K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):704-15. PubMed ID: 6198254
[TBL] [Abstract][Full Text] [Related]
13. Reduction of oxidized glutathione in normal and glucose-6-phosphate dehydrogenase deficient erythrocytes and their hemolysates.
Rieber EE; Jaffé ER
Blood; 1970 Feb; 35(2):166-72. PubMed ID: 5414698
[No Abstract] [Full Text] [Related]
14. The survival of glucose-6-phosphate dehydrogenase--deficient erythrocytes in patients with typhoid fever on chloramphenicol therapy.
Chan TK; Chesterman CN; McFadzean AJ; Todd D
J Lab Clin Med; 1971 Feb; 77(2):177-84. PubMed ID: 5540765
[No Abstract] [Full Text] [Related]
15. Grand rounds, University Hospital. G6PD deficiency.
Necheles TF
Bol Asoc Med P R; 1968 May; 60(5):246-61. PubMed ID: 5262255
[No Abstract] [Full Text] [Related]
16. Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
Jacobasch G; Bleiber R; Schönian G
Haematologia (Budap); 1982 Dec; 15(4):401-7. PubMed ID: 7186479
[TBL] [Abstract][Full Text] [Related]
17. Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjects.
Meloni T; Forteleoni G; Serra M; Daniotti S; Negri L; Giuntini P; Canepa L; Gaetani GF
J Clin Pharmacol; 1982; 22(8-9):418-20. PubMed ID: 7130431
[TBL] [Abstract][Full Text] [Related]
18. Catalase activity in normal and glucose-6-phosphate dehydrogenase deficient red cells.
Ezra R; Szeinberg A; Sheba C
Isr J Med Sci; 1965 Jul; 1(4):847-50. PubMed ID: 5856129
[No Abstract] [Full Text] [Related]
19. Reduced chronic hemolysis in Mediterranean glucose-6-phosphate dehydrogenase deficiency after vitamin E therapy.
Schulman JD; Corash L; Bartsocas C; Spielberg S; Boxer L; Sheetz M; Steinherz R; Papadatos C
Prog Clin Biol Res; 1979; 34():381-7. PubMed ID: 531063
[No Abstract] [Full Text] [Related]
20. [Systematic detection at birth of drug-induced hemolytic anemia caused by a toxic mechanism linked to an erythrocyte deficiency of glucose-6-phosphate dehydrogenase].
Collombel C; Kissen C; Dorche C; Baltassat P; Cotte J
Eur J Toxicol; 1970; 3(1):42-8. PubMed ID: 5520461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
